BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2616845)

  • 1. [The Mitroflow bioprosthesis. Results after 6 years].
    Revuelta JM; Bernal JM; Rabasa JM; Alonso C; Lequerica MA; Gutiérrez JA; Gaite L
    Rev Esp Cardiol; 1989 Nov; 42(9):614-9. PubMed ID: 2616845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitroflow heart valve: 5.5 years clinical experience.
    Revuelta JM; Bernal JM; Gutierrez JA; Gaite L; Alonso C; Durán CM
    Thorac Cardiovasc Surg; 1988 Oct; 36(5):262-5. PubMed ID: 3238662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Ionescu-Shiley bioprosthesis in the aortic position. Medium to long-term evaluation].
    Revuelta JM; Cacigas JC; Bernal JM; Alonso C; Lequerica MA; Gutiérrez JA; Gaite L
    Rev Esp Cardiol; 1989 Nov; 42(9):581-6. PubMed ID: 2616842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the Ionescu-Shiley pericardial valve in the aortic position: 100 months clinical experience.
    Revuelta JM; Durán CM
    Thorac Cardiovasc Surg; 1986 Aug; 34(4):247-51. PubMed ID: 2429393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early mechanical failures of the Hancock pericardial xenograft.
    Bortolotti U; Milano A; Thiene G; Guerra F; Mazzucco A; Valente M; Talenti E; Gallucci V
    J Thorac Cardiovasc Surg; 1987 Aug; 94(2):200-7. PubMed ID: 3613618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seventeen-year clinical results of 1,037 Mitroflow pericardial heart valve prostheses in the aortic position.
    Yankah CA; Schubel J; Buz S; Siniawski H; Hetzer R
    J Heart Valve Dis; 2005 Mar; 14(2):172-9; discussion 179-80. PubMed ID: 15792176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An eight-year experience with porcine bioprosthetic cardiac valves.
    Hartz RS; Fisher EB; Finkelmeier B; DeBoer A; Sanders JH; Moran JM; Michaelis LL
    J Thorac Cardiovasc Surg; 1986 Jun; 91(6):910-7. PubMed ID: 3713240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eighteen-year follow up after Hancock II bioprosthesis insertion.
    Legarra JJ; Llorens R; Catalan M; Segura I; Trenor AM; de Buruaga JS; Rabago G; Sarralde A
    J Heart Valve Dis; 1999 Jan; 8(1):16-24. PubMed ID: 10096477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous aortic and mitral valve replacement: predictors of adverse outcome.
    Kuwaki K; Tsukamoto M; Komatsu K; Morishita K; Sakata J; Abe T
    J Heart Valve Dis; 2003 Mar; 12(2):169-76. PubMed ID: 12701788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitroflow pericardial valve prosthesis in the aortic position: an analysis of long-term outcome and prognostic factors.
    Minami K; Boethig D; Mirow N; Kleikamp G; Koertke H; Godehardt E; Koerfer R
    J Heart Valve Dis; 2000 Jan; 9(1):112-22. PubMed ID: 10678383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of the MitroFlow pericardial bioprosthesis in the elderly after aortic valve replacement.
    Sjögren J; Gudbjartsson T; Thulin LI
    J Heart Valve Dis; 2006 Mar; 15(2):197-202. PubMed ID: 16607900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The homograft aortic valve: a 29-year, 99.3% follow up of 1,022 valve replacements.
    O'Brien MF; Harrocks S; Stafford EG; Gardner MA; Pohlner PG; Tesar PJ; Stephens F
    J Heart Valve Dis; 2001 May; 10(3):334-44; discussion 335. PubMed ID: 11380096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results with the Xenomedica porcine bioprosthesis in the mitral position.
    Santini F; Auriemma S; Casali G; Rossi A; Lusini M; Mazzucco A
    J Heart Valve Dis; 2001 Nov; 10(6):789-94. PubMed ID: 11767188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
    Goldsmith I; Lip GY; Mukundan S; Rosin MD
    J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The St. Jude Medical bileaflet valve prosthesis. A 5 year experience.
    Chaux A; Czer LS; Matloff JM; DeRobertis MA; Stewart ME; Bateman TM; Kass RM; Lee ME; Gray RJ
    J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 1):706-17. PubMed ID: 6492839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seven-year results with the St Jude Medical Silzone mechanical prosthesis.
    Jamieson WR; Fradet GJ; Abel JG; Janusz MT; Lichtenstein SV; MacNab JS; Stanford EA; Chan F
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1109-15.e2. PubMed ID: 19379975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aortic and mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 10-year results.
    Murakami T; Eishi K; Nakano S; Kobayashi J; Sasako Y; Isobe F; Kosakai Y; Kito Y; Kawashima Y
    J Heart Valve Dis; 1996 Jan; 5(1):45-9. PubMed ID: 8834725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aortic valve replacement with the Sorin Pericarbon Freedom stentless prosthesis: 7 years' experience in 130 patients.
    D'Onofrio A; Auriemma S; Magagna P; Favaro A; Cannarella A; Piccin C; Bilotta M; Abbiate N; Lamascese N; Fabbri A
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):491-5. PubMed ID: 17662795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aortic valve replacement with the Sorin Pericarbon Freedom stentless valve: five-year follow up.
    Nyawo B; Graham R; Hunter S
    J Heart Valve Dis; 2007 Jan; 16(1):42-8. PubMed ID: 17315382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aortic valve replacement with the Mitroflow pericardial bioprosthesis: durability results up to 21 years.
    Yankah CA; Pasic M; Musci M; Stein J; Detschades C; Siniawski H; Hetzer R
    J Thorac Cardiovasc Surg; 2008 Sep; 136(3):688-96. PubMed ID: 18805273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.